finmarketnews.com
news-details
Healthcare,healthcare stocks

3 Stocks Make It On Today's Healthcare & Biotech Stock Watchlist

 Powered by HealthTechMovers.com

We added 3 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.

In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention.  This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.

If you have other stocks that you are researching, then you need to Join TipRanks.com Now to get insights on every stock being traded!


Edwards Lifesciences, EW
Summary: Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
  • Last Price: 115.56
  • Price Change: -0.6, -0.52%
  • Yearly Gain: 32.48%
  • Market Cap: 72.15B
  • P/E Ratio: 49.365

Here are 3rd party ratings for EW:

  • TipRanks.com: Strong Buy
  • TradingView.com: Sell
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: Weak buy
  • Zacks.com: Hold, Bottom 39% (155 out of 254)

What is the sentiment on the street regarding Edwards Lifesciences (Current ratings compiled by TipRanks.com)

  • News Sentiment: Very Negative
  • Blogger Consensus: Bearish
  • Media Buzz: Medium
  • Insider Signal: Negative
  • Investor Sentiment: Very Negative
  • Hedge Fund signal: Negative

If you are interested in EW or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on EW before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Baxter International, BAX
Summary: Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
  • Last Price: 85.99
  • Price Change: 0.39, 0.46%
  • Yearly Gain: 8.99%
  • Market Cap: 43.05B
  • P/E Ratio: 36.077

Here are 3rd party ratings for BAX:

  • TipRanks.com: Strong Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong buy
  • Zacks.com: Strong Buy, Bottom 26% (187 out of 254)

What is the sentiment on the street regarding Baxter International (Current ratings compiled by TipRanks.com)

  • News Sentiment: Very Negative
  • Blogger Consensus: Bearish
  • Media Buzz: Very High
  • Insider Signal: Negative
  • Investor Sentiment: Very Negative
  • Hedge Fund signal: Very Negative

If you are interested in BAX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on BAX before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Compass Therapeutics, CMPX
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
  • Last Price: 2.68
  • Price Change: -0.15, -5.30%
  • Yearly Gain: -51.27%
  • Market Cap: 262.72M
  • P/E Ratio: -1.813

Here are 3rd party ratings for CMPX:

  • TipRanks.com: Strong Buy
  • TradingView.com: Sell
  • Yahoo! Finance: Bearish Short-Term Outlook
  • Barchart.com: n/a
  • Zacks.com: Hold, Bottom 41% (151 out of 254)

What is the sentiment on the street regarding Compass Therapeutics (Current ratings compiled by TipRanks.com)

  • News Sentiment: Very Negative
  • Blogger Consensus: Bearish
  • Media Buzz: High
  • Insider Signal: Negative
  • Investor Sentiment: Very Negative
  • Hedge Fund signal: No Signal

If you are interested in CMPX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CMPX before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------


Thanks for reading!